The ACTIV-2 Study is testing different medicines to see if they are safe and can help adults with COVID-19. Finding treatments for COVID-19 is important because the virus is spreading quickly all over the world and can cause serious sickness and even death.
Researchers want to see if the medicines are:
Can help people get better faster
Can get rid of the virus
Can keep people from getting sicker
Can prevent people from having to go to the hospital
Who can be in the ACTIV-2 Study?
The ACTIV-2 Study is for adults 18 years and older who:
Tested positive for COVID-19 (not more than 10 days ago)
Are at home (not in the hospital)
Have COVID-19 symptoms
You must have had at least one of the symptoms below within the last 10 days. In addition, you must have at least 1 of the symptoms shown below in blue within the last 24 hours.
What happens during the study?
The study lasts about 6 months. You will have in person visits to check on the status of your health. Most of these visits will happen during the first month of the study. You will also have phone calls or video chats from your home with a researcher.
If you agree to be in the study, you will give your permission by signing an informed consent form.
The informed consent contains all of the important information about the study. Ask questions and make sure you understand the study before signing the form.
You will answer some questions to make sure the study is right for you.
The screening may take place during a visit with a researcher, over the phone, or by video chat. If you meet with the researcher, you may also have a checkup.
3. Entry visit
You will meet with a researcher for tests and to be placed in a treatment group.
You will have some tests to check your heart, lungs, and general health, as well as a blood test and a nose swab. You will be placed in a treatment group by chance, like flipping a coin.
4. Treatment and clinic visits
Take the medicine exactly as the researcher explains to you. You will also have visits with a researcher for tests and phone calls from home with the researcher or nurse. The number of visits and phone calls you have will depend on the treatment you receive.
Most of the visits happen during the first 28 days of the study. You may have some of the following tests/health checks:
How do I join the study?
Have you tested positive for COVID-19 in the past 10 days? If so, you may be a good fit to join the ACTIV-2 Study and help us find a treatment for
COVID-19! Call to learn more.
Being in the study is completely voluntary. You can leave the study at any time.
Treatment vs Vaccine Study
You have probably heard about vaccine studies. But, what are treatment studies, and how do they differ?
Learn about different types of medicines that are being studied in the ACTIV-2 Study.
WE CAN RISE ABOVE COVID,
BUT WE CAN’T DO IT